Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Investigating the Role of PHIP (Pleckstrin Homology Domain Binding Interacting Protein)in Beta-cell Function

FY 2010-11

Summary
BACKGROUND: The ability of cells to communicate with and respond to their external environment relies on the fidelity of complex communication networks within the cell. Breakdown of these molecular networks is the underlying cause of many human diseases including cancer which culminates from the dysregulation of cell growth. In the cancer field, insulin-like growth factor-1 (IGF-1) has received increased attention as dysregulation of the IGF-1 pathway contributes to the development and metastatic dissemination of breast, prostate, and ovarian carcinomas. Our group has discovered a novel component of this pathway referred to as PHIP which may contribute to breast cancer development. PREVIOUS RESEARCH: Our recent findings indicate that the PHIP protein is markedly elevated in a number of breast cancers and cancer cell lines. In addition, we have observed that PHIP has marked effects on processes that enhance tumor cell growth and we have shown that PHIP can block the sensitivity of cancer cells to agents that are cytotoxic , ie. promote cell death. Significantly, we have discovered that agents that inhibit PHIP activity block the growth of breast and pancreatic cancer cells. PROJECT DESCRIPTION: The current proposal seeks to understand the precise molecular mechanisms by which PHIP regulates breast cancer growth and survival. We will use a combination of in vitro cell-based assays and pre-clinical animal models to study the role of PHIP in breast cancer disease IMPACT AND RELEVANCE: This proposal will help define the molecular mechanisms by which PHIP regulates the IGF-1 network and will allow us to gain insights as to how PHIP may promote cancer cell growth and metastasis. This area of research is of considerable clinical significance, as inhibition of the pathways regulated by PHIP may provide promising targets for therapeutic intervention in the treatment of not only breast but also of ovarian and prostate cancers.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
225398
Name
Balgobin Steve
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Investigating the Role of PHIP (Pleckstrin Homology Domain Binding Interacting Protein)in Beta-cell Function
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Molecular Biology; Oncogenes; Oncogenesis; Protein-Protein Interactions; Tumour Biology
Abstract
BACKGROUND: The ability of cells to communicate with and respond to their external environment relies on the fidelity of complex communication networks within the cell. Breakdown of these molecular networks is the underlying cause of many human diseases including cancer which culminates from the dysregulation of cell growth. In the cancer field, insulin-like growth factor-1 (IGF-1) has received increased attention as dysregulation of the IGF-1 pathway contributes to the development and metastatic dissemination of breast, prostate, and ovarian carcinomas. Our group has discovered a novel component of this pathway referred to as PHIP which may contribute to breast cancer development. PREVIOUS RESEARCH: Our recent findings indicate that the PHIP protein is markedly elevated in a number of breast cancers and cancer cell lines. In addition, we have observed that PHIP has marked effects on processes that enhance tumor cell growth and we have shown that PHIP can block the sensitivity of cancer cells to agents that are cytotoxic , ie. promote cell death. Significantly, we have discovered that agents that inhibit PHIP activity block the growth of breast and pancreatic cancer cells. PROJECT DESCRIPTION: The current proposal seeks to understand the precise molecular mechanisms by which PHIP regulates breast cancer growth and survival. We will use a combination of in vitro cell-based assays and pre-clinical animal models to study the role of PHIP in breast cancer disease IMPACT AND RELEVANCE: This proposal will help define the molecular mechanisms by which PHIP regulates the IGF-1 network and will allow us to gain insights as to how PHIP may promote cancer cell growth and metastasis. This area of research is of considerable clinical significance, as inhibition of the pathways regulated by PHIP may provide promising targets for therapeutic intervention in the treatment of not only breast but also of ovarian and prostate cancers.
Competitiondate
201102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Balgobin, Steve
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~